Assay of myo-inositol in cerebrospinal fluid and plasma by chemical ionization mass spectrometry of the hexaacetate derivative.
暂无分享,去创建一个
[1] B D Ross,et al. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. , 1993, Radiology.
[2] J. Growdon,et al. Evidence for a membrane defect in Alzheimer disease brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[3] N. Greig,et al. An automatic reaction control chemical ionization technique in ion trap detector for quantitative plasma profding of arecoline in treated alzheimer patients , 1991, Journal of the American Society for Mass Spectrometry.
[4] J. Haxby,et al. Lumbar cerebrospinal fluid choline in healthy aging and in Down's syndrome. , 1990, Archives of neurology.
[5] B. Fruen,et al. Down's syndrome fibroblasts exhibit enhanced inositol uptake. , 1990, The Biochemical journal.
[6] H. Chigasaki,et al. Polyol content of cerebrospinal fluid in brain-tumor patients. , 1989, Journal of neurosurgery.
[7] S. Rapoport,et al. Quantitative analysis of polyols in human plasma and cerebrospinal fluid. , 1989, Journal of chromatography.
[8] G. Glish,et al. Self chemical ionization in an ion trap mass spectrometer , 1988 .
[9] R. Foltz,et al. Chemical ionization with the ion trap detector: Application to a drug assay requiring a wide dynamic range , 1988 .
[10] G. Dijkstra,et al. Structure and formation of gaseous [C3H4N]+ ions† , 1986 .
[11] B. Wolf,et al. Quantitation of myo-inositol as its hexakis(trifluoroacetyl) derivative with negative ion chemical ionization mass spectrometry. , 1986, Biomedical & environmental mass spectrometry.
[12] B. Holub. Metabolism and function of myo-inositol and inositol phospholipids. , 1986, Annual review of nutrition.
[13] C. Swahn,et al. Gas Chromatographic‐Mass Spectrometric Determination of myo‐Inositol in Human Cerebrospinal Fluid , 1985, Journal of neurochemistry.
[14] A. Karmen,et al. Elevation of certain polyols in the cerebrospinal fluid of patients with multiple sclerosis. , 1984, Journal of chromatography.
[15] Michael J. Berridge,et al. Inositol trisphosphate, a novel second messenger in cellular signal transduction , 1984, Nature.
[16] J. Andersen,et al. Gas chromatographic mass spectrometric determination of myo-inositol in humans utilizing a deuterated internal standard. , 1982, Biomedical mass spectrometry.
[17] G. King,et al. The analysis of hexitols in biological fluid by selected ion monitoring. , 1980, Biomedical mass spectrometry.
[18] G. Höfle,et al. 4‐Dialkylaminopyridines as Highly Active Acylation Catalysts. [New synthetic method (25)] , 1978 .
[19] R. Fieve,et al. Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. , 1978, Biological psychiatry.
[20] J. Palo,et al. POLYOLS IN THE CEREBROSPINAL FLUID AND PLASMA OF NEUROLOGICAL, DIABETIC AND URAEMIC PATIENTS , 1977, Acta neurologica Scandinavica.
[21] W. Sherman,et al. Measurement of myo-inositol in single cells and defined areas of the nervous system by selected ion monitoring. , 1977, Analytical biochemistry.
[22] L. Lewin,et al. Elevated myo-inositol concentrations in cerebrospinal fluid of neonates and of patients with an impaired state of consciousness. , 1976, Biomedicine / [publiee pour l'A.A.I.C.I.G.].
[23] W. Sherman,et al. Combined gas chromatography-mass spectrometry of the inositol trimethylsilyl ethers and acetate esters , 1970 .